Korean J Dermatol.  2005 Oct;43(10):1316-1320.

A Clinical Study of 265 Patients with Vitiligo in the Gwangju Chonnam Province

Affiliations
  • 1Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea. schul@chonnam.ac.kr

Abstract

BACKGOUND: Vitiligo is a depigmentary disorder characterized by discrete, pale white macules. Its prevalence is approximately 1-2% of the general population. The pathogenesis of vitiligo is unknown, but genetic, biochemical and immunological hypothesis are proposed. OBJECTIVE: The aim of this study was to evaluate the clinical features of vitiligo and to compare the results with previous studies. METHOD: We evaluated the clinical features of 265 Korean vitiligo patients who lived in the Gwangju Chonnam Province (118 males and 147 females). RESULTS AND CONCLUSION: The mean age of the first visit and onset was 31.6+/-22 years (male: 29.0, female: 33.8) and 27.8+/-21 years (male: 24.8, female: 30.3) respectively. The most common interval between onset and visiting was within 6 months. The order of frequency in clinical types of vitiligo was vulgaris type (42.4%), focal type (31.4%), segmental type (14%) and acrofacial type (6.4%). The most common site of initial involvement was the face (37.4%) and the most common site of involvement was the face (27.6%). Precipitating factors, such as genetic tendency (7.6%), and trauma (3.8%), were found in 17.8% of patients. The prevalence of poliosis was 6.7% of vitiligo patients, and the eyebrow (50%) was the most common site of poliosis. Family history was found in 10.6% of patients, and associated diseases were found in 25.4% of patients. In conclusion, although this study is not helpful in evaluating the treatment response and the prognosis of vitiligo, this study is useful in providing some basic epidemiological data on vitiligo patients.

Keyword

Vitiligo; Clinical study

MeSH Terms

Eyebrows
Female
Gwangju*
Humans
Jeollanam-do*
Male
Molecular Biology
Precipitating Factors
Prevalence
Prognosis
Vitiligo*
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr